The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial

Omara Dogar; Deepa Barua; Melanie Boeckmann; Helen Elsey; Razia Fatima; Rhian Gabe; Rumana Huque; Ada Keding; Amina Khan; Daniel Kotz; Eva Kralikova; James N. Newell; Iveta Nohavova; Steve Parrott; Anne Readshaw; Lottie Renwick; Aziz Sheikh; Kamran Siddiqi; TB Tobacco Project Consortium

doi:10.1111/add.14242

The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial

Omara Dogar^*, Deepa Barua, Melanie Boeckmann, Helen Elsey, Razia Fatima, Rhian Gabe, Rumana Huque, Ada Keding, Amina Khan, Daniel Kotz, Eva Kralikova, James N. Newell, Iveta Nohavova, Steve Parrott, Anne Readshaw, Lottie Renwick, Aziz Sheikh, Kamran Siddiqi, TB Tobacco Project Consortium

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1716-1726
Number of pages	11
Journal	Addiction
Volume	113
Issue number	9
DOIs	https://doi.org/10.1111/add.14242
Publication status	Published - 1 Sep 2018

Keywords

Bangladesh
cytisine
low- and-middle income countries
Pakistan
placebo-controlled randomized trial
smoking cessation
tobacco cessation
tuberculosis
PULMONARY TUBERCULOSIS
TOBACCO-SMOKE
CESSATION
METAANALYSIS
SYMPTOMS
NICOTINE
WITHDRAWAL
COMPONENTS
PAKISTAN
CRITERIA

Access to Document

10.1111/add.14242

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.14242

Cite this

Dogar, O., Barua, D., Boeckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., Keding, A., Khan, A., Kotz, D., Kralikova, E., Newell, J. N., Nohavova, I., Parrott, S., Readshaw, A., Renwick, L., Sheikh, A., Siddiqi, K., & TB Tobacco Project Consortium (2018). The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial. Addiction, 113(9), 1716-1726. https://doi.org/10.1111/add.14242

Dogar, Omara ; Barua, Deepa ; Boeckmann, Melanie ; Elsey, Helen ; Fatima, Razia ; Gabe, Rhian ; Huque, Rumana ; Keding, Ada ; Khan, Amina ; Kotz, Daniel ; Kralikova, Eva ; Newell, James N. ; Nohavova, Iveta ; Parrott, Steve ; Readshaw, Anne ; Renwick, Lottie ; Sheikh, Aziz ; Siddiqi, Kamran ; TB Tobacco Project Consortium. / The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial. In: Addiction. 2018 ; Vol. 113, No. 9. pp. 1716-1726.

@article{53376ea304884392b174186d0ce92912,

title = "The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial",

keywords = "Bangladesh, cytisine, low- and-middle income countries, Pakistan, placebo-controlled randomized trial, smoking cessation, tobacco cessation, tuberculosis, PULMONARY TUBERCULOSIS, TOBACCO-SMOKE, CESSATION, METAANALYSIS, SYMPTOMS, NICOTINE, WITHDRAWAL, COMPONENTS, PAKISTAN, CRITERIA",

author = "Omara Dogar and Deepa Barua and Melanie Boeckmann and Helen Elsey and Razia Fatima and Rhian Gabe and Rumana Huque and Ada Keding and Amina Khan and Daniel Kotz and Eva Kralikova and Newell, {James N.} and Iveta Nohavova and Steve Parrott and Anne Readshaw and Lottie Renwick and Aziz Sheikh and Kamran Siddiqi and {TB Tobacco Project Consortium}",

year = "2018",

month = sep,

day = "1",

doi = "10.1111/add.14242",

language = "English",

volume = "113",

pages = "1716--1726",

journal = "Addiction",

issn = "0965-2140",

publisher = "Wiley",

number = "9",

}

Dogar, O, Barua, D, Boeckmann, M, Elsey, H, Fatima, R, Gabe, R, Huque, R, Keding, A, Khan, A, Kotz, D, Kralikova, E, Newell, JN, Nohavova, I, Parrott, S, Readshaw, A, Renwick, L, Sheikh, A, Siddiqi, K & TB Tobacco Project Consortium 2018, 'The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial', Addiction, vol. 113, no. 9, pp. 1716-1726. https://doi.org/10.1111/add.14242

The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial. / Dogar, Omara; Barua, Deepa; Boeckmann, Melanie; Elsey, Helen; Fatima, Razia; Gabe, Rhian; Huque, Rumana; Keding, Ada; Khan, Amina; Kotz, Daniel; Kralikova, Eva; Newell, James N.; Nohavova, Iveta; Parrott, Steve; Readshaw, Anne; Renwick, Lottie; Sheikh, Aziz; Siddiqi, Kamran; TB Tobacco Project Consortium.

In: Addiction, Vol. 113, No. 9, 01.09.2018, p. 1716-1726.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial

AU - Dogar, Omara

AU - Barua, Deepa

AU - Boeckmann, Melanie

AU - Elsey, Helen

AU - Fatima, Razia

AU - Gabe, Rhian

AU - Huque, Rumana

AU - Keding, Ada

AU - Khan, Amina

AU - Kotz, Daniel

AU - Kralikova, Eva

AU - Newell, James N.

AU - Nohavova, Iveta

AU - Parrott, Steve

AU - Readshaw, Anne

AU - Renwick, Lottie

AU - Sheikh, Aziz

AU - Siddiqi, Kamran

AU - TB Tobacco Project Consortium

PY - 2018/9/1

Y1 - 2018/9/1

KW - Bangladesh

KW - cytisine

KW - low- and-middle income countries

KW - Pakistan

KW - placebo-controlled randomized trial

KW - smoking cessation

KW - tobacco cessation

KW - tuberculosis

KW - PULMONARY TUBERCULOSIS

KW - TOBACCO-SMOKE

KW - CESSATION

KW - METAANALYSIS

KW - SYMPTOMS

KW - NICOTINE

KW - WITHDRAWAL

KW - COMPONENTS

KW - PAKISTAN

KW - CRITERIA

U2 - 10.1111/add.14242

DO - 10.1111/add.14242

M3 - Article

C2 - 29676824

VL - 113

SP - 1716

EP - 1726

JO - Addiction

JF - Addiction

SN - 0965-2140

IS - 9

ER -